Toggle Main Menu Toggle Search

Open Access padlockePrints

Production of immunosuppressive factors by a cultured tumor cell line and their effect on lymphocyte proliferation and cells cycle response

Lookup NU author(s): Dr Ian Brotherick, Dr Brian Shenton, Emeritus Professor John Kirby, Dr Jeremy Palmer, Emeritus Professor Steve Yeaman, Professor Thomas Lennard

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Immunosuppression observed in patients with malignancy may be due to factors released by tumour cells. Medium conditioned by COLO 205 cells was found to inhibit mitogen-stimulated lymphocyte proliferation. Examination of CD25 and Class II MHC induction on PBMC incubated in complete, or COLO205 conditioned, medium was not Significant. The prevalence of lymphocytes in the S-phase of the cell cycle was enhanced after mitogenic stimulation and addition of COLO 205 conditioned medium. This was balanced by a concomitant fall in proportion of cells in the G(0)/G(1) phases of the cell cycle. The immunosuppressive properties of COLO 205 conditioned medium was abrogated by heating to 60 degrees C for 30 min and by digestion with trypsin. Fractionation of the medium by gel filtration yielded two immunosuppressive fractions with relative molecular weights of 60,000 and below 20,000. It was concluded that cultured COLO 205 cells produce immunosuppressive protein/peptide factors which block cell proliferation during DNA synthesis. These factors fail to prevent upregulation of membrane-associated markers of cell activation.


Publication metadata

Author(s): Brotherick I, Shenton BK, Kirby JA, Rigg KM, Palmer JM, Yeaman SJ, Lennard TWJ

Publication type: Article

Publication status: Published

Journal: Surgical Oncology

Year: 1993

Volume: 2

Issue: 4

Pages: 241-248

Print publication date: 01/08/1993

ISSN (print): 0960-7404

ISSN (electronic): 1879-3320

URL: http://dx.doi.org/10.1016/0960-7404(93)90013-O

DOI: 10.1016/0960-7404(93)90013-O


Altmetrics

Altmetrics provided by Altmetric


Share